Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Strategies for treating and managing chronic hepatitis C in children in the direct-acting antiviral era

  • Hong, Suk-Jin (Department of Pediatrics, School of Medicine, Daegu Catholic University) ;
  • Choe, Byung-Ho (Department of Pediatrics, School of Medicine, Kyungpook National University)
  • Received : 2019.06.16
  • Accepted : 2019.11.03
  • Published : 2020.02.15
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. World Health Organization. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection [Internet]. Geneva (Switzerland): World Health Organization; 2018 [cited 2019 Sep 15]. Available from: https://www.who.int/hepatitis/publications/hepatitisc-guidelines-2018.
  2. Kim BK, Jang ES, Kim JH, Park SY, Ahn SV, Kim HJ, et al. Current status of and strategies for hepatitis C control in South Korea. Clin Mol Hepatol 2017;23:212-8. https://doi.org/10.3350/cmh.2017.0105
  3. Indolfi G, Serranti D, Resti M. Direct-acting antivirals for children and adolescents with chronic hepatitis C. Lancet Child Adolesc Health 2018;2:298-304. https://doi.org/10.1016/s2352-4642(18)30037-3
  4. Wirth S, Ribes-Koninckx C, Calzado MA, Bortolotti F, Zancan L, Jara P, et al. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol 2010;52:501-7. https://doi.org/10.1016/j.jhep.2010.01.016
  5. Rashed YK, Khalaf FA, Kotb SE. Thyroid disturbances in children treated with combined Pegylated Interferon alpha and Ribavirin for chronic hepatitis C. Clin Exp Pediatr 2020;63:52-5. https://doi.org/10.3345/kjp.2018.07150
  6. Mandac JC, Chaudhry S, Sherman KE, Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 2006;43:661-72. https://doi.org/10.1002/hep.21146
  7. Hwang Y, Kim W, Kwon SY, Yu HM, Kim JH, Choe WH. Incidence of and risk factors for thyroid dysfunction during peginterferon ${\alpha}$ and ribavirin treatment in patients with chronic hepatitis C. Korean J Intern Med 2015;30:792-800. https://doi.org/10.3904/kjim.2015.30.6.792
  8. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol 2018;69:461-511. https://doi.org/10.1016/j.jhep.2018.03.026
  9. The American Association for the Study of Liver Diseases, the Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C [Internet]. AASLD, IDSA;[cited 2019 Sep 14]. Available from: https://www.hcvguidelines.org.